Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDSX NYSEAMERICAN:CCEL OTCMKTS:PFHO NASDAQ:PIII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDSXBiodesix$0.43-4.4%$0.36$0.17▼$2.04$62.55M11.46 million shs5.23 million shsCCELCryo-Cell International$4.70-1.1%$4.84$4.09▼$9.43$37.88M0.6717,551 shs9,485 shsPFHOPacific Health Care Organization$1.23-1.2%$0.94$0.65▼$1.34$15.74M0.1325,726 shs4,907 shsPIIIP3 Health Partners$8.28-0.4%$6.83$5.80▼$29.19$59.53M0.827,537 shs6,316 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDSXBiodesix0.00%-5.91%+17.46%+37.70%-78.23%CCELCryo-Cell International0.00%+2.62%-5.24%-5.43%-10.65%PFHOPacific Health Care Organization0.00%+17.14%+35.46%+46.43%+53.46%PIIIP3 Health Partners0.00%+15.16%+12.65%+17.78%-67.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBDSXBiodesix3.4912 of 5 stars3.45.00.00.03.32.50.6CCELCryo-Cell International3.4983 of 5 stars3.53.01.70.03.73.30.0PFHOPacific Health Care Organization0.637 of 5 stars0.03.00.00.00.61.71.3PIIIP3 Health Partners2.1725 of 5 stars3.32.00.00.02.20.81.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDSXBiodesix 2.80Moderate Buy$1.75310.22% UpsideCCELCryo-Cell International 3.00Buy$8.5080.85% UpsidePFHOPacific Health Care Organization 0.00N/AN/AN/APIIIP3 Health Partners 2.50Moderate Buy$16.2596.26% UpsideCurrent Analyst Ratings BreakdownLatest PFHO, BDSX, PIII, and CCEL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025PIIIP3 Health PartnersLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$20.00(Data available from 9/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDSXBiodesix$76.56M0.82N/AN/A$0.14 per share3.05CCELCryo-Cell International$31.99M1.18$0.18 per share26.22($1.64) per share-2.87PFHOPacific Health Care Organization$6.07M2.59$0.07 per share17.15$0.91 per share1.35PIIIP3 Health Partners$1.50B0.04N/AN/A$10.58 per share0.78Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDSXBiodesix-$42.93M-$0.29N/AN/AN/A-53.66%-269.67%-43.94%11/7/2025 (Estimated)CCELCryo-Cell International$400K-$1.06N/A∞N/A-0.53%-1.07%-0.27%N/APFHOPacific Health Care Organization$880K$0.1012.30∞N/A21.18%11.76%11.09%10/30/2025 (Estimated)PIIIP3 Health Partners-$135.85M-$46.01N/AN/AN/A-9.99%-183.60%-17.83%11/11/2025 (Estimated)Latest PFHO, BDSX, PIII, and CCEL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025PIIIP3 Health Partners-$3.29-$6.23-$2.94-$6.23$356.52 million$355.79 million8/7/2025Q2 2025BDSXBiodesix-$0.07-$0.08-$0.01-$0.08$18.47 million$20.02 million7/31/2025Q2 2025PFHOPacific Health Care OrganizationN/A$0.05N/A$0.05N/A$1.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBDSXBiodesixN/AN/AN/AN/AN/ACCELCryo-Cell International$0.6012.77%N/AN/A N/APFHOPacific Health Care OrganizationN/AN/AN/AN/AN/APIIIP3 Health PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDSXBiodesix41.112.142.14CCELCryo-Cell InternationalN/A0.600.57PFHOPacific Health Care OrganizationN/A18.9418.94PIIIP3 Health Partners2.290.310.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDSXBiodesix20.96%CCELCryo-Cell International10.44%PFHOPacific Health Care OrganizationN/APIIIP3 Health Partners7.75%Insider OwnershipCompanyInsider OwnershipBDSXBiodesix30.10%CCELCryo-Cell International36.86%PFHOPacific Health Care Organization61.60%PIIIP3 Health Partners17.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDSXBiodesix220146.63 million102.50 millionOptionableCCELCryo-Cell International908.06 million5.09 millionNot OptionablePFHOPacific Health Care Organization3012.80 million4.92 millionNot OptionablePIIIP3 Health Partners5007.19 million5.91 millionNot OptionablePFHO, BDSX, PIII, and CCEL HeadlinesRecent News About These CompaniesP3 Health Partners' (PIII) "Buy" Rating Reiterated at Lake Street CapitalAugust 30 at 8:57 AM | marketbeat.comCresset Asset Management LLC Buys 50,000 Shares of P3 Health Partners Inc. $PIIIAugust 30 at 3:51 AM | marketbeat.comP3 Health Partners (NASDAQ:PIII) Coverage Initiated by Analysts at Lake Street CapitalAugust 29 at 2:51 AM | americanbankingnews.comCatalyst Solutions Announces Successful Launch of P3 Implementation Across Four StatesAugust 25, 2025 | prnewswire.comP3 Health Partners Inc. (PIII) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comP3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue EstimatesAugust 14, 2025 | zacks.comP3 Health Partners Announces Second Quarter 2025 ResultsAugust 14, 2025 | businesswire.comP3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference CallJuly 31, 2025 | businesswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.July 28, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.July 22, 2025 | globenewswire.comP3 Health Partners Inc. (PIII) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 16, 2025 | globenewswire.comBears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' NowJune 12, 2025 | zacks.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 6, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 3, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.May 27, 2025 | globenewswire.comDown 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)May 26, 2025 | zacks.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.May 23, 2025 | globenewswire.comP3 Health Partners Inc. (NASDAQ:PIII) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comP3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look ForMay 16, 2025 | finance.yahoo.comP3 Health Partners Inc (PIII) Q1 2025 Earnings Call Highlights: Strategic Adjustments and ...May 16, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePFHO, BDSX, PIII, and CCEL Company DescriptionsBiodesix NASDAQ:BDSX$0.43 -0.02 (-4.44%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.45 +0.02 (+5.72%) As of 08/29/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.Cryo-Cell International NYSEAMERICAN:CCEL$4.70 -0.05 (-1.05%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$4.72 +0.02 (+0.43%) As of 08/29/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.Pacific Health Care Organization OTCMKTS:PFHO$1.23 -0.02 (-1.20%) As of 08/29/2025 03:55 PM EasternPacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, employee advocate services, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves insurers, third party administrators, self-administered employers, municipalities, and other industries. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California.P3 Health Partners NASDAQ:PIII$8.28 -0.03 (-0.36%) Closing price 08/29/2025 03:58 PM EasternExtended Trading$8.28 0.00 (0.00%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
